Fycompa (perampanel) is a prescription drug used to treat seizures in people with epilepsy. Fycompa can cause side effects that range from mild to serious. Examples include fatigue, sleepiness, and ...
TOKYO, Dec 20, 2022 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the United States (U.S.) commercial rights for the anti-epileptic drug (AED) ...
TOKYO, Aug 2, 2021 - (JCN Newswire) - - Eisai Co., Ltd. announced today that its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic name: perampanel) has obtained two ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...
With Eisai on the verge of scoring a potential approval for its Biogen-partnered Alzheimer’s disease drug lecanemab, the Japanese pharma is thinking big. Monday, Eisai inked a deal to unload one of ...
Perampanel is a non-competitive antagonist of the ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor on post-synaptic neurons. Glutamate is the primary ...
child yellow pill medicine Safety data for Fycompa was consistent with the safety profile in adult populations without the need for weight-based dosing. The Food and Drug Administration has expanded ...
WOODCLIFF LAKE, N.J., Aug. 19, 2013 /PRNewswire via COMTEX/ -- Eisai Inc. filed a petition today with the U.S. Court of Appeals for the District of Columbia asking the court to direct the Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results